Biosimilar Products

Biocon on Friday said its partner Fujifilm Pharma Co has launched its biosimilar product Insulin Glargine in Japan after receiving approval from the Japanese health authority earlier this year.

The collaboration agreement involves the import of biosimilars that are currently unavailable in Turkey, especially for the treatment of cancer, Zydus Group firm Cadila Healthcare said in a filing to BSE.

Biocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country. The Ministry of Health, Labour and Welfare (MHLW) of Japan has approved the sale of Glargine, a significant achievement for Biocon and its commercial partner, Fujifilm Pharma, the biotech major said in a filing to BSE.

Pharma major Dr Reddy's Laboratories Ltd has entered into a strategic collaboration agreement with Turkey-based TR-Pharm involving three biosimilar products.

MUMBAI, AUGUST 25Phone: +91 (22) 6147 5100. feedback@tickerplantindia.com Copyright (c) TickerPlant Ltd.Copyright (c) TickerPlant Ltd.

Biocon on Friday said its partner Fujifilm Pharma Co has launched its biosimilar product Insulin Glargine in Japan after receiving approval from the Japanese health authority earlier this year.

The collaboration agreement involves the import of biosimilars that are currently unavailable in Turkey, especially for the treatment of cancer, Zydus Group firm Cadila Healthcare said in a filing to BSE.

Biocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country. The Ministry of Health, Labour and Welfare (MHLW) of Japan has approved the sale of Glargine, a significant achievement for Biocon and its commercial partner, Fujifilm Pharma, the biotech major said in a filing to BSE.

Pharma major Dr Reddy's Laboratories Ltd has entered into a strategic collaboration agreement with Turkey-based TR-Pharm involving three biosimilar products.

MUMBAI, AUGUST 25Phone: +91 (22) 6147 5100. feedback@tickerplantindia.com Copyright (c) TickerPlant Ltd.Copyright (c) TickerPlant Ltd.